- SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development
Mahboubeh Zarei, Alireza Zakeri, Saeed Khalili *, Zahra Sadat Hashemi - Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System
Maryam Mashhadi Abolghasem Shirazi, Mina Hannan, Golnaz Bahramali, Mohammad Reza Aghasadeghi, Seyed Mehdi Sadat * - In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii
Samira Sabzi, Farzad Badmasti, Narjes Noori Goodarzi, Mehri Habibi, Shahla Shahbazi, Mohammd Reza Asadi Karam, Mehdi Farokhi * - Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens
Sheida Hedayat, Mehri Habibi *, Reza Hosseini Doust, Mohammad Reza Asadi Karam - In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella
Babak Beikzadeh *, Shahrzad Ahangarzadeh - Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate
Hassan Yarmohammadi, Abbas Akhavan Sepahi, Mojtaba Hamidi-Fard, Mohammadreza Aghasadeghi *, Golnaz Bahramali
- Year 2023
- Year 2022
- Year 2021
- Year 2020
- Year 2019
Accepted Articles
Journal Information
- Current Issue: 2023، Volume 10، Number 1
- Print ISSN: 2383-2819
- Online ISSN: 2423-4923
- Director-in-Charge: Mohammad Reza Aghasadeghi
- Editor-in-Chief: Mohammad Reza Aghasadeghi
- Publisher: Pasteur Institute of Iran
Indexing Databases
Newsletter subscription
Enter your email address to have site news and announcements delivered directly to your inbox.
Site Statistics
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.